|
Beyond dopamine imaging - full neurotransmitter landscape in Parkinson’s disease
|
|
1
|
43
|
May 12, 2026
|
|
What are the intended/best ways to select MR images for download, matched to subject data?
|
|
7
|
72
|
May 1, 2026
|
|
Webinar - Investigation of Surrogate Imaging Markers for Early Diagnosis and Risk Stratification in Parkinson’s Disease
|
|
14
|
188
|
February 18, 2026
|
|
Cross-Modal Harmonization: Can We Standardize Imaging Signatures Across Centers?
|
|
2
|
55
|
November 2, 2025
|
|
🧠 Imaging Subgroup | Data Modality & Methodology Task Force
|
|
1
|
52
|
October 14, 2025
|
|
Understanding the DaTScan data in the PPMI Curated Data Cut
|
|
11
|
309
|
September 11, 2025
|
|
Assessing brain atrophy rates using SIENA based on longitudinal MRI datasets from different scanners/protocols
|
|
1
|
64
|
August 14, 2025
|
|
Functional Connectivity in Parkinson’s: Biomarker or Bystander?
|
|
3
|
86
|
June 3, 2025
|
|
GitHub Repository for Imaging Data Processing and Community Collaboration
|
|
5
|
98
|
May 19, 2025
|
|
Accessing and analysing DaTscan images
|
|
2
|
135
|
April 9, 2025
|
|
Neuroimaging in Clinical Trials
|
|
2
|
78
|
March 13, 2025
|
|
Current Knowledge on Imaging Markers of Parkinson’s Disease
|
|
1
|
83
|
October 20, 2024
|
|
Matching MRI sessions in PPMI
|
|
4
|
125
|
October 9, 2024
|